Research Topics
Genomes and GenesSpecies | S ZeuzemSummaryAffiliation: Frankfurt am Main Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirinS Zeuzem
Johann Wolfgang Goethe University Medical Center, Frankfurt am Main, Germany
J Viral Hepat 19:766-74. 2012..No threshold could be identified in HCV genotype 2 or 3 patients. A threshold HCV RNA level of 400,000 IU/mL is optimal for differentiating high and low probability of SVR in genotype 1-infected individuals with elevated ALT...
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkersJohannes Vermehren
Medizinische Klinik 1, Klinikum der J, W, Goethe Universitat, Frankfurt am Main, Germany
BMC Gastroenterol 12:27. 2012..Our aim was to determine the prevalence of liver fibrosis and associated risk factors in HIV-infected individuals based on non-invasive fibrosis assessment using transient elastography (TE) and serum biomarkers (Fibrotest [FT])...
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled studyGeert Bezemer
Dpt, Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
BMC Gastroenterol 12:11. 2012..HRQL improves after successful treatment. This trial explores the course of and factors associated with HRQL in patients given individualized or standard treatment based on early treatment response (Ditto-study)...
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis CStefan Zeuzem
University Hospital, JW Goethe University, Frankfurt, Germany
Hepatology 55:749-58. 2012..Transient elevations in serum bilirubin occurred in all treatment groups. CONCLUSION: In genotype 1 HCV, adding RBV or RBV with Peg-IFN provides additive antiviral activity to combination therapy with tegobuvir and GS-9256...
Telaprevir for the treatment of hepatitis CNicole Forestier
J W Goethe University Hospital, Department of Medicine, 1, Theodor Stern Kai 7, 60590 Frankfurt Main, Germany
Expert Opin Pharmacother 13:593-606. 2012..At present, there are several next-generation DAAs in clinical development in combination with Peg-IFN-α. The future, however, may also include new treatment strategies, such as oral DAA combinations...
Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infectionStefan Zeuzem
J W Goethe University Hospital, Frankfurt, Germany
Gastroenterology 141:2047-55; quiz e14. 2011..We investigated the antiviral effect and safety of BI 201335 (an inhibitor of the NS3/4A protease) and BI 207127 (an inhibitor of the NS5B non-nucleoside polymerase) with ribavirin...
Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virusChristoph Welsch
Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, 66123 Saarbrucken, Germany
Genome Biol 9:R16. 2008..These mutations are located in the protein interior and far away from the ligand binding pocket...
HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortalityNikolai Mühlberger
Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, UMIT University of Health Sciences, Medical Informatics and Technology, Hall iT, Austria
BMC Public Health 9:34. 2009..We summarised burden of disease data presently available for Europe, compared the data to current expert estimates, and identified areas in which better data are needed...
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisMireen Friedrich-Rust
Department of Internal Medicine 1, JW Goethe University Hospital, Frankfurt, Germany
BMC Gastroenterol 10:103. 2010..While a systematic review has shown comparable results for both individual markers, there has been no direct comparison of both markers...
Interleukin-12 in the treatment of chronic hepatitis B and CS Zeuzem
Medizinische Klinik II, Zentrum der Inneren Medizin, Klinikum der Johann Wolfgang Goethe Universitat, Theodor Stern Kai 7, D 60590 Frankfurt am Main, Germany
Antiviral Res 52:181-8. 2001..5 microg/kg dose group. In conclusion, antiviral activity of rHuIL-12 in patients with chronic hepatitis B or C does not appear to be advantageous in comparison to other currently available treatments...
The kinetics of hepatitis C virus infectionS Zeuzem
Department of Medicine, Division of Gastroenterology and Hepatology, University of Frankfurt a M, Germany
Clin Liver Dis 5:917-30. 2001..Nonresponding patients typically show constant viremia or even a rebound during this second phase...
Dynamic evolution of therapy for chronic hepatitis C: how will novel agents be incorporated into the standard of care?Stefan Zeuzem
JW Goethe University Hospital, Frankfurt, Germany
Antivir Ther 13:747-60. 2008..The treatment paradigm for chronic hepatitis C continues to evolve and will eventually incorporate new drugs as they are approved...
Telaprevir for retreatment of HCV infectionStefan Zeuzem
Johann Wolfgang Goethe University Medical Center, Frankfurt am Main, Germany
N Engl J Med 364:2417-28. 2011..Up to 60% of patients with hepatitis C virus (HCV) genotype 1 infection do not have a sustained virologic response to therapy with peginterferon alfa plus ribavirin...
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1Stefan Zeuzem
JW Goethe University Hospital, Frankfurt, Germany
Gastroenterology 139:1257-66. 2010..We evaluated the efficacy/safety of albinterferon alfa-2b (albIFN), a novel, long-acting, genetic fusion polypeptide of albumin and IFNα-2b...
Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapyS Zeuzem
Medizinische Klinik II, Zentrum der Inneren Medizin, Klinikum der Johann Wolfgang Goethe Universitat, Theodor Stern Kai 7, D 60590 Frankfurt a M, Germany
Expert Opin Investig Drugs 10:2201-13. 2001..The advantages of PEG-IFN alfa-2a were also seen in patients with cirrhosis or hepatitis C virus (HCV) genotype 1...
[Pegylated interferon plus ribavirin in chronic hepatitis C. More than half of patients show a lasting response]S Zeuzem
Medizinische Klinik II, Zentrum der Inneren Medizin, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt Main
MMW Fortschr Med 144:30-4. 2002..In the meantime, concrete treatment recommendations are available for every genetic type of HCV, for patients experiencing relapse, and for primary treatment failures...
Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic responseStefan Zeuzem
Department of Medicine I, J W Goethe University Hospital, Frankfurt, Germany
Curr Med Res Opin 26:1733-43. 2010..However, recent studies have shown that on-treatment markers of virologic response can be used to tailor treatment duration according to each patient's response to therapy...
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis BStefan Zeuzem
Klinikum der Johann Wolfgang Goethe Universitat, Theodor Stern Kai 7, 60590 Frankfurt a Main, Germany
J Hepatol 51:11-20. 2009..In the GLOBE trial, telbivudine treatment was identified as a significant, independent predictor of better outcomes at 2 years. We analyzed all telbivudine recipients in this trial to determine the predictors of optimal outcomes...
Interferon-based therapy for chronic hepatitis C: current and future perspectivesStefan Zeuzem
Department of Medicine, JW Goethe University Hospital, Frankfurt, Germany
Nat Clin Pract Gastroenterol Hepatol 5:610-22. 2008..These compounds will be used, at least initially, in combination with peginterferon alpha plus ribavirin, extending the pivotal role of interferon-based therapy in the management of chronic hepatitis C...
Peginterferon alfa-2a in patients with chronic hepatitis CS Zeuzem
Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt, Germany
N Engl J Med 343:1666-72. 2000..We compared the clinical effects of a regimen of peginterferon alfa-2a with those of a regimen of interferon alfa-2a in the initial treatment of patients with chronic hepatitis C...
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis CS Zeuzem
Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt, Germany
Hepatology 29:1280-7. 1999..In conclusion, antiviral activity of rHuIL-12 in patients with chronic hepatitis C does not appear advantageous in comparison with other currently available treatments...
Clinical implications of hepatitis C viral kineticsS Zeuzem
Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt a M, Germany
J Hepatol 31:61-4. 1999....
Gut-liver axisS Zeuzem
Medizinische Klinik II, Zentrum der Inneren Medizin, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt a M, Germany
Int J Colorectal Dis 15:59-82. 2000..Furthermore, the liver is the primary organ for metastasis of intestinal cancer. Many viral, bacterial, fungal, and parasitic diseases affect the intestine as well as the liver and the biliary tract...
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis CStefan Zeuzem
JW Goethe University Hospital, Frankfurt, Germany
Hepatology 48:407-17. 2008..1 versus 4.3 days; P = 0.006). CONCLUSION: Alb-IFN administered q2wk or q4wk may offer comparable efficacy, with an improved dosing schedule, compared with PEG-IFNalpha-2a...
Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis CS Zeuzem
Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt a M, Germany
Hepatology 32:835-41. 2000..In conclusion, combination therapy IFN-alpha plus amantadine is as effective as IFN-alpha monotherapy in previously untreated patients with chronic hepatitis C...
What is (cost) effective in patients with chronic hepatitis C virus infection?S Zeuzem
Medizinische Klinik II, Zentrum der Inneren Medizin, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt aM, Germany
Eur J Gastroenterol Hepatol 13:473-6. 2001..g. by long-acting pegylated interferons), will have new impact on antiviral efficacy and cost effectiveness...
Expert opinion on the treatment of patients with chronic hepatitis CS Zeuzem
Zentrum der Inneren Medizin, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt, Germany
J Viral Hepat 16:75-90. 2009....
Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genomeU Mihm
Medizinische Klinik I, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt Main, Germany
J Viral Hepat 17:217-21. 2010..In conclusion, Ribavirin-induced mutagenesis did not increase RNase L cleavage sites (UU/UA dinucleotides) within the HCV NS3 or NS5B encoding regions...
Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis CG Teuber
Medizinische Klinik II, , Frankfurt, Germany
J Viral Hepat 8:276-83. 2001....
Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancerJ Raedle
Second Department of Internal Medicine, Johann Wolfgang Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt am Main, Germany
Ann Intern Med 135:566-76. 2001..The Bethesda guidelines were established to identify patients with colorectal cancer who should be tested for microsatellite instability...
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2aS Zeuzem
Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt am Main, Germany
Gastroenterology 120:1438-47. 2001..The aim of the study was to compare viral kinetics in patients treated with standard or peginterferon alpha2a...
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2bJ Vermehren
Medizinische Klinik 1, Klinikum der J W Goethe Universitat, Frankfurt am Main, Germany
J Viral Hepat 19:120-7. 2012..Sequential short-term dosing of boceprevir was not associated with accumulation of resistant variants but pre-existing variants may impair virologic response...
Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolatesM W Welker
Klinikum der Johann Wolfgang Goethe Universitat, Medizinische Klinik 1, Frankfurt am Main, Germany
J Viral Hepat 18:181-92. 2011..The variability in the CD81 binding regions appeared to be independent from CD81 expression...
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapyW P Hofmann
Department of Internal Medicine I, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany
J Viral Hepat 15:790-6. 2008..Antiviral therapy leads to an on-treatment increase of BMD, which may last in those patients who achieve a sustained virological response...
Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipperM W Welker
Klinikum der Johann Wolfgang Goethe Universitat, Medizinische Klinik, Theodor Stern Kai, Frankfurt am Main, Germany
J Viral Hepat 19:775-83. 2012..RNA replication efficacy can be modulated by site-directed mutagenesis at specific bZIP functional sites. New adaptive amino acid mutations were identified within the HCV NS4B protein...
Efficacy and safety of sorafenib in advanced hepatocellular carcinoma under daily practice conditionsM W Welker
Medizinische Klinik1, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt am Main, Germany
J Chemother 22:205-11. 2010..In conclusion, in daily practice sorafenib is safe and disease stabilization can be achieved in the majority of patients. However, intolerance to sorafenib can affect treatment adherence substantially...
Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapyC Sarrazin
Medizinische Klinik II, , Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
Virology 289:150-63. 2001....
Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis CM Friedrich-Rust
Department of Internal Medicine, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
J Viral Hepat 16:168-77. 2009....
Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2aC Sarrazin
Medizinische Klinik II, , 60590 Frankfurt am Main, Germany
J Clin Microbiol 39:2850-5. 2001....
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver diseaseM Friedrich-Rust
Department of Internal Medicine 1, J W Goethe University Hospital, Frankfurt, Germany
Ultraschall Med 30:478-84. 2009..The aim of the present study was to validate real-time elastography using the formulas calculated in previous studies and to compare the results to transient elastography and FibroTest for the noninvasive assessment of liver fibrosis...
Randomized, controlled trial with IFN-alpha combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis CGerlinde Teuber
Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe Universitat, Theodor Stern Kai 7, D 60590 Frankfurt M, Germany
J Hepatol 39:606-13. 2003..Efficacy and safety of interferon-alpha (IFN-alpha)/ribavirin retreatment with or without amantadine sulphate were evaluated in non-responders with chronic hepatitis C...
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogsJ Peveling-Oberhag
Department of Internal Medicine 1, J W Goethe University Hospital, Frankfurt, Germany
J Viral Hepat 20:234-9. 2013..Further studies are needed to confirm HBV quasispecies evolution as additional predictive marker for beneficial treatment outcome...
New developments in HCV therapyB Kronenberger
Department of Internal Medicine 1, Hospital of the Johann Wolfgang Goethe University, Frankfurt am Main, Germany
J Viral Hepat 19:48-51. 2012..Several studies have been initiated that combine different novel therapies, with and without interferon α/ribavirin...
Peri-hepatic lymphadenopathy in primary biliary cirrhosis reflects progression of the diseaseC F Dietrich
Medizinische Klinik II, Johann Wolfgang Goethe Universitat, Germany
Eur J Gastroenterol Hepatol 11:747-53. 1999..We prospectively investigated the peri-hepatic lymph node volume in patients with primary biliary cirrhosis (PBC) and healthy controls to evaluate the correlation with histology, biochemical and immunological features...
Interferon alfa down-regulates CD81 in patients with chronic hepatitis CB Kronenberger
Medizinische Klinik II, , , Frankfurt am Main, Frankfurt am Main, Germany
Hepatology 33:1518-26. 2001..5 vs. 139.8 +/- 27.5 RFU; P =.057). In conclusion, IFN-alpha and ribavirin regulate CD81 expression in vitro and in vivo. CD81 expression correlates with HCV genotype and initial virologic response in patients with chronic hepatitis C...
Characterization of the nuclear import of human MutLalphaA Brieger
Medizinische Klinik I, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt a M, Germany
Mol Carcinog 43:51-8. 2005....
Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infectionO Waidmann
Medizinische Klinik 1, Schwerpunkt Gastroenterologie und Hepatologie, Klinikum der Goethe Universität, Frankfurt Main, Germany
J Viral Hepat 19:e58-65. 2012..Furthermore, serum miR-122 levels discriminated HBV carrier patients with high or low risk for disease progression and may, thus, be an additional marker for risk stratification...
Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infectionO Schroder
Department of Nuclear Medicine, Johann Wolfgang Goethe University, Frankfurt Main, Germany
Nuklearmedizin 37:279-85. 1998..The differentiation of HCC from liver metastasis or benign disorders by imaging studies based upon morphological aspects may be difficult...
Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapyC M Lange
Department of Medicine, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
Aliment Pharmacol Ther 32:14-28. 2010..Novel, directly acting anti-viral agents, also named 'specifically targeted anti-viral therapy for hepatitis C' (STAT-C) compounds, are currently under development...
Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissueB Ruster
Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe Universitat, D 60590 Frankfurt a M, Germany
J Med Virol 63:128-34. 2001..These observations might have important implications on the pathology of HCV, especially its potential tumorigenicity...
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infectionJ Peveling-Oberhag
Department of Internal Medicine 1, J W Goethe University Hospital, Frankfurt, Germany
Leukemia 26:1654-62. 2012..0016). In conclusion, there is a characteristic dysregulation of miRNA expression in SMZL with a possible implication in its molecular tumorigenesis...
MUTYH hotspot mutations in unselected colonoscopy patientsM Casper
Department of Medicine II, Saarland University Medical Centre, Homburg, Germany
Colorectal Dis 14:e238-44. 2012..Y179C and p.G396D account for the majority of pathogenic variants of MUTYH in Caucasians. Our aim was to evaluate the prevalence of MUTYH mutations in a prospective cohort of unselected patients with different colorectal diseases...
Activation of a cryptic splice site of PTEN and loss of heterozygosity in benign skin lesions in Cowden diseaseJ Trojan
Second Department of Medicine, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
J Invest Dermatol 117:1650-3. 2001..In conclusion, our data demonstrate that a PTEN splicing site mutation causes activation of a cryptic splice site, which results in aberrant transcripts...
[Hypertransaminasaemia and impaired liver function in a patient with oligosymptomatic celiac disease]W P Hofmann
Medizinische Klinik II, , Frankfurt/Main, Germany
Z Gastroenterol 39:1027-32. 2001..Serum aminotransferase levels normalized within 6 months. The clinical course demonstrates involvement of the liver in patients with celiac disease...
13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infectionB Braden
Medical Department II, University Hospital, Frankfurt Main, Germany
Aliment Pharmacol Ther 21:179-85. 2005..The 13C-methacetin breath test enables the quantitative evaluation of the cytochrome P450-dependent liver function...
[44-year-old patient with fulminant liver failure]A Kerber
Medizinische Klinik II, Zentrum der Inneren Medizin, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt
Internist (Berl) 44:1301-7. 2003..The case represents the yet oldest patient reported with an acute manifestation of Wilson's disease...
Clinical relevance of HCV antiviral drug resistanceC Welsch
J W Goethe University Hospital, Department of Internal Medicine I, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
Curr Opin Virol 2:651-5. 2012..Knowledge on molecular escape mechanisms of resistant variants, their time to wild-type reversal and potential persistence is of upmost importance to design treatment strategies for patients with previous DAA-treatment failure...
Peroral cholangioscopy for diagnosis and therapy of biliary tract disease using an ultra-slim gastroscopeJ G Albert
Department of Medicine I, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany
Endoscopy 43:1004-9. 2011..This technique should only be performed using CO2 insufflation...
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysisM Friedrich-Rust
Department of Internal Medicine 1, JW Goethe University Hospital, Frankfurt, Germany
J Viral Hepat 19:e212-9. 2012..91 for the diagnosis of severe fibrosis (F ≥ 3), and 0.93 for the diagnosis of cirrhosis. ARFI can be performed with good diagnostic accuracy for the noninvasive staging of liver fibrosis...
[Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests]W P Hofmann
Medizinische Klinik 1, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt am Main
Z Gastroenterol 46:1283-9. 2008..Besides other dynamic tests, the indocyanine green (ICG) clearance and the monoethylglycinxylid (MEGX) clearance tests have been satisfactorily evaluated...
A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardationJ Raedle
2nd Department of Internal Medicine and Institute of Human Genetics, University of Frankfurt/Main, Frankfurt am Main, Germany
Am J Gastroenterol 96:3016-20. 2001..If the deletion encompasses the APC gene, these patients are at high risk of developing FAP and associated complications...
[Clinical aspects of liver cirrhoses and its complications and diagnostic problems]M Huber
Medizinische Klinik II, Zentrum der Inneren Medizin, , Theodor-Stern-Kai 7, 60590 Frankfurt
Radiologe 41:840-51. 2001..Therapeutic management should mainly focus on the treatment of the underlying chronic liver disease in a precirrhotic stage. In the case of cirrhosis, prevention and treatment of complications are clinically most important...
Pertussis toxin inhibits cholecystokinin- and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1A Piiper
Department of Internal Medicine, Johann Wolfgang Goethe University, Frankfurt, Germany
Mol Pharmacol 58:608-13. 2000....
Hepatitis C viral kinetic modelsE Herrmann
Department of Medicine, Saarland University Hospital, Germany
Cell Death Differ 10:S7-8. 2003
[Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients]M von Wagner
Medizinische Klinik I, Johann Wolfgang Goethe Universitat Frankfurt, Frankfurt a M, Germany
Dtsch Med Wochenschr 134:255-8. 2009..In case of bone marrow transplantation prophylaxis with nucleos(t)idanalogue has to be initiated before onset of treatment if anti-HBc is detectable, independent from HBsAg result...
TH1/TH2 serum cytokine profiles and soluble TNF-receptor response in patients with chronic hepatitis C during recombinant human interleukin-12 (rHuIL-12) treatmentG Teuber
Medizinische Klinik II, , Frankfurt, Germany
Z Gastroenterol 40:487-95. 2002..This may offer an explanation for the unsatisfactory clinical efficiency of the substance...
[Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results]T J Vogl
Institut für Diagnostische und Interventionelle Radiologie, J W Goethe Universitat, Frankfurt
Rofo 179:1113-26. 2007..The local tumor response reaches up to 88% and the bleeding control is from 83 to 100%. CONCLUSION: TACE is a potentially curative, palliative, neoadjuvant, bridging and symptomatic therapy option for local and diffuse HCC...
Subcellular distribution and function of Rab3A-D in pancreatic acinar AR42J cellsA Piiper
Department of Medicine II, University of Frankfurt Main, Frankfurt, 60590, Germany
Biochem Biophys Res Commun 287:746-51. 2001..In conclusion, our data indicate that the different Rab3 proteins show distinct subcellular distribution, suggesting different impact on exocrine secretory response in dexamethasone-differentiated AR42J cells...
Frequency of the Amsterdam criteria in a regional German cohort of patients with colorectal cancerJ Raedle
Medizinische Klinik II, Klinikum der J W Goethe Universitat, Frankfurt Main, Germany
Z Gastroenterol 40:561-8. 2002..However, the final diagnosis of HNPCC can only be established by detection of pathogenic germline mutations within the DNA mismatch repair genes...
[Diagnostic imaging in liver cirrhosis]R M Hammerstingl
Institut für Diagnostische und Interventionelle Radiologie, Johann Wolfgang Goethe Universitat, ZRAD Haus 23 A, Theodor Stern Kai 7, 60590 Frankfurt am Main
Radiologe 41:852-67. 2001..This technique is the optimal protocol for diagnostic imaging in patients suffering from liver cirrhosis and the method of choice to reach the final diagnosis...
Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infectionT Konrad
Department of Internal Medicine and ndash I, Research Group for Clinical Physiology and Transplantation Physiology, J W Goethe University, Frankfurt a M, Germany
Digestion 62:52-9. 2000....
Nodular regenerative hyperplasia of the liver: a rare differential diagnosis of cholestasis with response to ursodeoxycholic acidD Faust
2nd Department of Internal Medicine and Gastroenterology, Johann Wolfgang Goethe-University, Frankfurt, Germany
Z Gastroenterol 41:255-8. 2003..Based on this case, it may be concluded that treatment with ursodeoxycholic acid might be beneficial in patients with NRHL and progression to liver insufficiency...
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodulesM Friedrich-Rust
Department of Internal Medicine 1, JW Goethe University Hospital, Frankfurt, Germany
Exp Clin Endocrinol Diabetes 118:602-9. 2010..The aim of the present study was to evaluate real-time elastography (RTE) and contrast-enhanced ultrasound with Sonovue (CEUS) for the differentiation of benign and malignant thyroid nodules...
[Transient elastography (FibroScan) for the non-invasive assessment of liver fibrosis: current status and perspectives]M Friedrich-Rust
Medizinische Klinik I, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt am Main
Z Gastroenterol 45:387-94. 2007..In addition, several studies have shown, that the FibroScan can be applied to estimate the risk of complications associated with liver cirrhosis...
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based studyI Blumenstein
First Department of Internal Medicine, Division of Gastroenterology, Goethe University Hospital, Theodor Stern Kai 7, 60590 Frankfurt Main, Germany
J Crohns Colitis 5:203-10. 2011..The aim of the present study was to evaluate gender-related differences in the treatment of a distinct IBD patient population treated in the Rhein-Main region, Germany...
Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human mesangial cellsU F Mondorf
Department of Medicine, Division of Nephrology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590, Frankfurt am Main, Germany
FEBS Lett 472:129-32. 2000..In conclusion, our data show that Ang II-induced activation of mitogenic signalling cascade in human mesangial cells involves ligand-independent activation of the PDGFR, but not of the coexpressed EGFR...
Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variantsA Brieger
Medizinische Klinik II, , Frankfurt, Germany
Gut 51:677-84. 2002..This method is applicable for the functional definition of mutations in hMLH1 and hMSH2 genes observed in patients with suspected HNPCC...
[Magnetic resonance cholangiopancreatography (MRCP) from a radiological and gastroenterological perspective]T J Vogl
Institut für Diagnostische und Interventionelle Radiologie, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt am Main
Dtsch Med Wochenschr 134:1011-4. 2009..MRCP is integrated in the preinterventional concept for performing invasive endoscopic retrograde cholangiopancreatography (ERCP) and for follow-up post intervention and for diagnosing complications...
Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trialMatthias M Dollinger
Department of Medicine I, Martin Luther University Halle Wittenberg, Germany
BMC Cancer 10:457. 2010..The aim of this study was to assess the efficacy of thymostimulin in a phase III trial...
Expression and release of IL-18 binding protein in response to IFN-gammaJ Paulukat
Pharmazentrum Frankfurt and Second Department of Medicine, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt am Main, Germany
J Immunol 167:7038-43. 2001..Down-regulation of IL-18BPa by sodium butyrate suggests that reinforcement of local IL-18 activity may contribute to actions of this short-chain fatty acid in the colonic microenvironment...
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseStephanos J Hadziyannis
Department of Medicine and Hepatology, Henry Dunant Hospital, Athens, Greece
Ann Intern Med 140:346-55. 2004..Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C...
Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?Stefan Zeuzem
Department of Internal Medicine II, Saarland University Hospital, Homburg Saar, Germany
Ann Intern Med 140:370-81. 2004..This article reviews the data on interferon-based therapies among patients with lower chances for sustained virologic response and discusses the potential of the new pegylated interferons...
Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis CUlrike Mihm
, , Kirrberger Strasse, D-66421 Homburg/Saar, Germany
J Hepatol 40:845-52. 2004..Thus, the conclusion from in vitro studies that the upregulation of interleukin-8 by the hepatitis C virus contributes to the inhibition of the antiviral actions of interferon-alpha may also be applicable in vivo...
Dynamics of hepatitis C virus infectionStefan Zeuzem
Department of Medicine, University Hospital Homburg/Saar, Germany
Ann Hepatol 1:56-63. 2002..This second phase decay is predictive for the virologic end-of-treatment and even more the sustained response. Non-responding patients typically show constant viremia or even a rebound during this second phase...
Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3Stefan Zeuzem
Department of Medicine, Saarland University Hospital, Homburg Saar, Germany
J Hepatol 40:993-9. 2004..The aim of the present study was to investigate this schedule for HCV-2/3 infected patients in the era of pegylated interferon-alpha plus ribavirin...
Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?Stefan Zeuzem
J Hepatol 41:488-90. 2004
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infectionMichael von Wagner
Johann Wolfgang Goethe Universitat, Frankfurt, Main, Germany
Hepatology 48:1404-11. 2008..CONCLUSION: In this large placebo-controlled multicenter study, amantadine even at a dose of 400 mg/day did not improve virological response rates of peginterferon alfa-2a and ribavirin in patients with chronic genotype HCV-1 infection...
Pegylated interferon monotherapy for chronic hepatitis CJenny Heathcote
Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
Semin Liver Dis 24:39-45. 2004..0 microg/kg dose and achieved 25% compared with 12% in the standard IFN group. In conclusion, each regimen of pegylated IFN given once weekly is more effective than a regimen of standard IFN given three times weekly...
Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levelsBernd Kronenberger
, , Homburg/Saar, Germany
Hepatology 40:1442-9. 2004..These data show that virological response in patients with chronic hepatitis C is less associated with baseline ALT than with GGT levels...
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levelsStefan Zeuzem
Saarland University Hospital, Homburg Saar, Germany
Gastroenterology 127:1724-32. 2004....
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trialHarry L A Janssen
Department of Gastroenterology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
Lancet 365:123-9. 2005..Treatment of HBeAg-positive patients with chronic hepatitis B is not effective in most. A combination of immunomodulatory pegylated interferon alfa-2b and antiviral lamivudine might improve the rate of sustained response...
Pharmacokinetics of peginterferonsStefan Zeuzem
Department of Medicine, Division of Gastroenterology, Hepatology, and Endocrinology, Saarland University Hospital, Homburg Saar, Germany
Semin Liver Dis 23:23-8. 2003..However, it remains unknown whether these differences in the initial viral decline predict differences in the primary clinical endpoint, sustained virological response...
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis CDaniele Prati
Ospedale A Manzoni, Lecco and IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy
J Hepatol 44:679-85. 2006..To clarify the role and interactions of viral and host factors in inducing liver cell injury, we examined the associations of several virological and metabolic variables with serum alanine aminotransferase levels...
Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression systemJoerg Trojan
Second Department of Medicine, Johann Wolfgang Goethe University, Frankfurt a M, Germany
Gastroenterology 122:211-9. 2002..To date, functional analysis of missense mutations has been performed primarily in Saccharomyces cerevisiae. The aim of this study was to examine the biochemical properties of hMLH1 protein variants in a human expression system...
Viral dynamics in chronic hepatitis B patients during lamivudine therapyLonieke M M Wolters
Department of Hepatogastroenterology, University Hospital Rotterdam, The Netherlands
Liver 22:121-6. 2002..The bi-phasic model as described by Neumann et al. in combination with frequent blood sampling provides the most accurate fit and can be used to compare new nucleoside analogue profiles to lamivudine therapy...
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)Samuel S Lee
Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1
J Hepatol 37:500-6. 2002..We evaluated the prognostic value of baseline factors and early viral RNA among patients treated with peginterferon alfa-2a (40KD)...
Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cellsAlbrecht Piiper
Department of Internal Medicine and Institute for Biochemistry II, Johann Wolfgang Goethe University, D 60590 Frankfurt, Germany
J Biol Chem 277:43623-30. 2002....
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis CMarkus Cornberg
Department of Gastroenterology, Hepatology, and Endocrinology, Medizinische Hochschule Hannover, Carl Neuberg Strasse 1, D-30625 Hannover, Germany
J Hepatol 37:843-7. 2002..These data suggest that inhibition of the IMPDH seems not to be the major mechanism of ribavirin in enhancing the antiviral effect of interferon alfa in chronic hepatitis C...
Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase CepsilonAlbrecht Piiper
Department of Internal Medicine II, University of the Saarland, D 66421 Homburg Saar, Germany
J Biol Chem 278:7065-72. 2003....
Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptorAlbrecht Piiper
Department of Internal Medicine, University of Saarland, D 66421, Homburg Saar, Germany
Biochem Biophys Res Commun 301:848-54. 2003..While PKA may directly phosphorylate the EGFR on serine residues, PKA-induced tyrosine phosphorylation of the EGFR occurs by an indirect mechanism...
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapyThomas Berg
Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, , Campus Virchow-Klinikum, , Berlin, Germany
Hepatology 37:600-9. 2003..This algorithm recognizes 53.7% of nonresponders previously identified at week 24 of treatment...
